Live Earnings Conference Call: Phreesia will host a live Q1 2026 earnings call on May 28, 2025 at 8:30AM ET. Get details.

Phreesia (PHR) Financials

$24.88 +0.82 (+3.41%)

Closing price 05/27/2025 03:59 PM Eastern

Extended Trading

$25.92 +1.04 (+4.18%)

As of 04:14 AM Eastern

Compare

Annual Income Statements for Phreesia

This table shows Phreesia's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2025	2024	2023	2022	2021	2020	2019	2018
Period end date	1/31/2025	1/31/2024	1/31/2023	1/31/2022	1/31/2021	1/31/2020	1/31/2019	1/31/2018
Net Income / (Loss) Attributable to Common Shareholders	-59	-137	-176	-118	-27	-91	-45	-38
Consolidated Net Income / (Loss)	-59	-137	-176	-118	-27	-20	-15	-18
Net Income / (Loss) Continuing Operations	-59	-137	-176	-118	-27	-20	-15	-18
Total Pre-Tax Income	-56	-135	-176	-118	-27	-22	-15	-18
Total Operating Income	-58	-136	-177	-117	-26	-15	-9.49	-15
Total Gross Profit	285	232	172	132	96	80	63	50
Total Revenue	420	356	281	213	149	125	100	80
Operating Revenue	420	356	281	213	149	125	100	80
Total Cost of Revenue	135	124	109	81	52	45	37	30
Operating Cost of Revenue	135	124	109	81	52	45	37	30
Total Operating Expenses	343	369	348	249	122	95	72	65
Selling, General & Admin Expense	77	80	80	69	40	30	20	19
Marketing Expense	121	147	151	106	43	32	26	25
Research & Development Expense	117	112	91	52	23	19	14	11
Depreciation Expense	14	18	18	15	9.77	8.75	7.55	6.83
Amortization Expense	14	12	7.32	6.32	6.14	5.17	4.04	2.81
Total Other Income / (Expense), net	2.29	1.14	0.89	-1.16	-1.57	-6.78	-5.57	-3.64
Interest Expense	0.00	1.12	0.00	1.08	1.57	2.45	3.50	3.64
Interest & Investment Income	0.33	2.21	1.06	-	-	-	-	-
Other Income / (Expense), net	1.96	0.04	-0.18	-0.08	0.00	-4.33	-2.07	0.00
Income Tax Expense	2.72	1.54	0.48	0.18	0.05	-1.78	0.00	0.00
Basic Earnings per Share	($1.02)	($2.51)	($3.36)	($2.37)	($0.69)	($4.50)	($24.53)	($24.81)
Weighted Average Basic Shares Outstanding	57.59M	54.56M	52.44M	49.89M	39.52M	20.30M	1.84M	1.54M
Diluted Earnings per Share	($1.02)	($2.51)	($3.36)	($2.37)	($0.69)	($4.50)	($24.53)	($24.81)
Weighted Average Diluted Shares Outstanding	57.59M	54.56M	52.44M	49.89M	39.52M	20.30M	1.84M	1.54M
Weighted Average Basic & Diluted Shares Outstanding	58.77M	56.39M	53.36M	51.95M	39.52M	20.30M	1.84M	1.54M

This table shows Phreesia's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Period end date	1/31/2025	10/31/2024	7/31/2024	4/30/2024	1/31/2024	10/31/2023	7/31/2023	4/30/2023	1/31/2023	10/31/2022	7/31/2022
Net Income / (Loss) Attributable to Common Shareholders	-6.39	-14	-18	-20	-31	-32	-37	-38	-38	-40	-47
Consolidated Net Income / (Loss)	-6.39	-14	-18	-20	-31	-32	-37	-38	-38	-40	-47
Net Income / (Loss) Continuing Operations	-6.39	-14	-18	-20	-31	-32	-37	-38	-38	-40	-47
Total Pre-Tax Income	-5.38	-14	-17	-19	-30	-32	-36	-37	-38	-40	-47
Total Operating Income	-7.61	-14	-17	-19	-30	-32	-37	-38	-40	-40	-46
Total Gross Profit	76	72	69	67	63	61	56	53	49	46	40
Total Revenue	110	107	102	101	95	92	86	84	77	73	68
Operating Revenue	110	107	102	101	95	92	86	84	77	73	68
Total Cost of Revenue	34	35	33	34	32	31	30	31	28	27	27
Operating Cost of Revenue	34	35	33	34	32	31	30	31	28	27	27
Total Operating Expenses	84	86	87	87	93	93	92	91	88	86	87
Selling, General & Admin Expense	18	20	19	19	19	20	21	20	20	20	20
Marketing Expense	29	30	30	32	36	36	37	37	36	37	38
Research & Development Expense	30	29	30	29	30	29	27	26	25	23	23
Depreciation Expense	3.17	3.57	3.92	3.52	4.35	4.48	4.24	4.50	4.63	4.87	4.22
Amortization Expense	3.65	3.52	3.38	3.15	3.90	2.98	2.54	2.49	2.30	1.82	1.60
Total Other Income / (Expense), net	2.24	-0.12	-0.04	0.21	-0.85	0.48	0.84	0.68	1.62	-0.15	-0.17
Interest & Investment Income	0.02	0.03	0.05	0.24	0.18	0.52	0.79	0.72	-	-	-
Other Income / (Expense), net	2.22	-0.14	-0.09	-0.03	0.08	-0.05	0.05	-0.04	0.03	-0.21	0.04
Income Tax Expense	1.01	0.44	0.75	0.51	0.22	0.37	0.65	0.31	-0.17	0.21	0.21
Basic Earnings per Share	($0.11)	($0.25)	($0.31)	($0.35)	($0.55)	($0.58)	($0.68)	($0.70)	($0.72)	($0.76)	($0.89)
Weighted Average Basic Shares Outstanding	57.59M	57.89M	57.50M	56.67M	54.56M	55.25M	53.79M	53.35M	52.44M	52.61M	52.33M
Diluted Earnings per Share	($0.11)	($0.25)	($0.31)	($0.35)	($0.55)	($0.58)	($0.68)	($0.70)	($0.72)	($0.76)	($0.89)
Weighted Average Diluted Shares Outstanding	57.59M	57.89M	57.50M	56.67M	54.56M	55.25M	53.79M	53.35M	52.44M	52.61M	52.33M
Weighted Average Basic & Diluted Shares Outstanding	58.77M	58.12M	57.77M	57.40M	56.39M	55.63M	55.21M	53.66M	53.36M	52.75M	52.53M

This table details how cash moves in and out of Phreesia's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2025	2024	2023	2022	2021	2020	2019	2018
Period end date	1/31/2025	1/31/2024	1/31/2023	1/31/2022	1/31/2021	1/31/2020	1/31/2019	1/31/2018
Net Change in Cash & Equivalents	-3.30	-89	-137	95	128	89	-8.96	8.18
Net Cash From Operating Activities	32	-32	-90	-75	2.89	0.83	-2.13	-11
Net Cash From Continuing Operating Activities	32	-32	-90	-75	2.89	0.83	-2.13	-11
Net Income / (Loss) Continuing Operations	-59	-137	-176	-118	-27	-20	-15	-18
Consolidated Net Income / (Loss)	-59	-137	-176	-118	-27	-20	-15	-18
Depreciation Expense	28	29	25	21	16	14	12	9.64
Amortization Expense	2.05	1.38	2.01	2.50	2.41	2.42	2.44	2.29
Non-Cash Adjustments To Reconcile Net Income	67	75	62	38	16	11	1.59	-0.37
Changes in Operating Assets and Liabilities, net	-6.28	-1.41	-3.43	-18	-4.16	-6.53	-2.69	-4.51
Net Cash From Investing Activities	-24	-40	-26	-65	-25	-12	-11	-12
Net Cash From Continuing Investing Activities	-24	-40	-26	-65	-25	-12	-11	-12
Purchase of Property, Plant & Equipment	-24	-25	-26	-31	-19	-12	-9.83	-12
Acquisitions	0.00	-15	0.00	-34	-6.51	-	-1.19	0.00
Net Cash From Financing Activities	-11	-17	-21	235	151	100	4.19	31
Net Cash From Continuing Financing Activities	-11	-17	-21	235	151	100	4.19	31
Repayment of Debt	-1.35	-2.68	-0.61	-1.16	-23	-39	-8.30	-24
Issuance of Debt	0.00	1.69	0.00	0.00	-	30	15	22
Issuance of Common Equity	2.92	3.21	3.32	248	175	131	0.00	0.00
Other Financing Activities, net	-13	-19	-24	-12	-1.20	-0.09	-2.11	0.15
Effect of Exchange Rate Changes	-0.11	0.00	0.00	-	-	-	-	-
Cash Interest Paid	2.19	1.31	0.76	0.80	1.47	2.31	2.80	2.80
Cash Income Taxes Paid	3.07	0.04	0.04	0.05	0.06	0.00	0.00	-

This table details how cash moves in and out of Phreesia's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Period end date	1/31/2025	10/31/2024	7/31/2024	4/30/2024	1/31/2024	10/31/2023	7/31/2023	4/30/2023	1/31/2023	10/31/2022	7/31/2022
Net Change in Cash & Equivalents	2.48	-0.06	2.27	-7.99	-16	-24	-22	-27	-33	-31	-28
Net Cash From Operating Activities	16	5.79	11	-0.72	-3.08	-6.31	-9.33	-14	-16	-21	-20
Net Cash From Continuing Operating Activities	16	5.79	11	-0.72	-3.08	-6.31	-9.33	-14	-16	-21	-20
Net Income / (Loss) Continuing Operations	-6.39	-14	-18	-20	-31	-32	-37	-38	-38	-40	-47
Consolidated Net Income / (Loss)	-6.39	-14	-18	-20	-31	-32	-37	-38	-38	-40	-47
Depreciation Expense	6.82	7.09	7.30	6.67	8.25	7.46	6.78	6.99	6.92	6.68	5.82
Amortization Expense	0.17	1.38	0.24	0.25	0.27	0.32	0.36	0.43	0.46	0.50	0.51
Non-Cash Adjustments To Reconcile Net Income	16	18	17	17	20	19	19	18	16	16	16
Changes in Operating Assets and Liabilities, net	0.03	-6.01	4.98	-5.28	-0.54	-0.84	1.30	-1.33	-1.43	-3.46	4.99
Net Cash From Investing Activities	-7.06	-4.18	-7.40	-5.45	-8.16	-16	-9.72	-6.08	-6.60	-6.73	-5.85
Net Cash From Continuing Investing Activities	-7.06	-4.18	-7.40	-5.45	-8.16	-16	-9.72	-6.08	-6.60	-6.73	-5.85
Purchase of Property, Plant & Equipment	-7.06	-4.18	-7.40	-5.45	-7.86	-5.31	-5.84	-6.08	-6.60	-6.73	-5.85
Net Cash From Financing Activities	-6.63	-1.65	-1.38	-1.83	-4.61	-2.28	-3.04	-7.18	-10	-3.66	-2.77
Net Cash From Continuing Financing Activities	-6.63	-1.65	-1.38	-1.83	-4.61	-2.28	-3.04	-7.18	-10	-3.66	-2.77
Repayment of Debt	-0.31	-0.30	-0.30	-0.44	-2.11	-0.27	-0.30	0.00	-	-	-0.50
Issuance of Common Equity	0.48	0.84	0.69	0.91	0.43	0.92	0.90	0.97	0.49	0.88	0.74
Other Financing Activities, net	-6.79	-2.19	-1.78	-2.30	-2.93	-2.93	-5.33	-8.15	-11	-4.55	-3.00
Effect of Exchange Rate Changes	-0.09	-0.01	-0.01	-0.00	-	-	-	0.00	-	-	-
Cash Interest Paid	0.74	0.60	0.38	0.48	0.66	0.30	0.30	0.06	0.12	0.20	0.32
Cash Income Taxes Paid	0.51	0.55	0.42	1.59	-0.01	-0.01	0.01	0.04	-	-	-

This table presents Phreesia's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2025	2024	2023	2022	2021	2020	2019
Period end date	1/31/2025	1/31/2024	1/31/2023	1/31/2022	1/31/2021	1/31/2020	1/31/2019
Total Assets	388	370	370	494	327	159	59
Total Current Assets	203	196	262	386	272	132	33
Cash & Equivalents	84	88	177	314	219	90	1.54
Accounts Receivable	74	65	51	40	29	22	16
Prepaid Expenses	16	14	11	11	7.25	5.16	3.81
Other Current Assets	30	29	24	21	17	14	12
Plant, Property, & Equipment, net	24	17	22	0.00	0.00	14	14
Total Noncurrent Assets	161	158	86	108	54	13	12
Goodwill	76	76	34	34	8.31	0.25	0.25
Intangible Assets	81	78	47	30	13	9.93	9.25
Other Noncurrent Operating Assets	4.73	4.13	5.58	44	32	1.77	2.23
Total Liabilities & Shareholders' Equity	388	370	370	494	327	159	59
Total Liabilities	124	119	82	77	63	57	64
Total Current Liabilities	114	110	79	68	55	35	28
Short-Term Debt	8.04	6.06	5.17	5.82	4.86	2.32	1.97
Accounts Payable	5.62	8.48	11	5.12	4.39	6.02	3.75
Accrued Expenses	37	37	22	20	18	9.24	5.51
Current Deferred Revenue	33	24	18	16	11	5.40	6.49
Other Current Liabilities	30	34	24	21	17	12	10
Total Noncurrent Liabilities	9.58	8.76	3.20	8.76	8.37	22	36
Long-Term Debt	8.15	5.40	2.73	7.42	6.47	22	28
Noncurrent Deferred Revenue	0.12	0.10	0.13	0.07	-	-	-
Noncurrent Deferred & Payable Income Tax Liabilities	0.48	0.27	0.00	-	-	-	-
Other Noncurrent Operating Liabilities	0.83	2.99	0.35	1.28	1.90	0.00	5.50
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	265	251	288	417	263	102	-211
Total Preferred & Common Equity	265	251	288	417	263	102	-211
Preferred Stock	0.00	0.00	0.00	-	-	-	-
Total Common Equity	265	251	288	417	263	102	-211
Common Stock	1,112	1,040	927	861	580	387	0.02
Retained Earnings	-801	-743	-606	-430	-312	-284	-211
Treasury Stock	-46	-46	-34	-14	-4.97	-0.40	0.00
Accumulated Other Comprehensive Income / (Loss)	-0.05	0.00	-	-	-	-	-

This table presents Phreesia's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	10/31/2024	7/31/2024	4/30/2024	10/31/2023	7/31/2023	4/30/2023	10/31/2022	7/31/2022	4/30/2022	10/31/2021
Total Assets	376	362	372	375	340	354	397	426	459	529
Total Current Assets	190	181	191	199	219	240	287	316	349	464
Cash & Equivalents	82	82	80	103	128	150	210	241	269	400
Accounts Receivable	71	61	66	57	54	53	44	47	46	35
Prepaid Expenses	11	12	14	14	12	10	11	7.72	11	10
Other Current Assets	25	26	31	25	26	27	22	21	23	18
Plant, Property, & Equipment, net	26	21	22	20	0.00	0.00	0.00	0.00	0.00	0.00
Total Noncurrent Assets	160	160	159	156	121	114	110	109	110	65
Goodwill	76	76	76	75	41	34	34	34	34	8.21
Intangible Assets	80	80	79	77	54	49	44	40	35	16
Other Noncurrent Operating Assets	3.98	4.86	4.23	3.28	26	31	33	36	41	40
Total Liabilities & Shareholders' Equity	376	362	372	375	340	354	397	426	459	529
Total Liabilities	121	111	119	110	93	90	77	78	78	71
Total Current Liabilities	109	102	108	98	85	83	73	72	71	65
Short-Term Debt	8.87	7.16	7.75	6.75	7.11	6.98	5.48	5.72	6.10	4.60
Accounts Payable	16	6.98	6.68	11	7.95	7.60	11	10	5.87	12
Accrued Expenses	29	33	33	28	28	23	20	18	18	19
Current Deferred Revenue	22	21	24	22	16	18	14	17	18	12
Other Current Liabilities	33	34	37	30	26	27	22	21	23	17
Total Noncurrent Liabilities	12	8.90	11	12	8.55	7.26	4.23	5.58	7.09	6.25
Long-Term Debt	10	7.30	8.69	6.85	8.06	6.69	3.77	4.93	6.00	5.13
Noncurrent Deferred Revenue	0.20	0.06	0.08	0.10	0.10	0.18	0.00	0.01	0.15	-
Noncurrent Deferred & Payable Income Tax Liabilities	0.45	0.39	0.33	0.22	0.18	0.14	-	-	-	-
Other Noncurrent Operating Liabilities	0.97	1.15	1.96	4.46	0.22	0.26	0.46	0.63	0.95	1.12
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	255	251	253	265	247	264	320	348	381	458
Total Preferred & Common Equity	255	251	253	265	247	264	320	348	381	458
Preferred Stock	0.00	0.00	0.00	-	-	-	-	-	-	-
Total Common Equity	255	251	253	265	247	264	320	348	381	458
Common Stock	1,095	1,078	1,061	1,022	972	948	912	897	881	850
Retained Earnings	-795	-781	-763	-712	-680	-644	-568	-528	-481	-383
Treasury Stock	-46	-46	-46	-46	-44	-41	-24	-20	-19	-8.56
Accumulated Other Comprehensive Income / (Loss)	-0.01	-0.00	0.00	-	-	-	-	-	-	-

This table displays calculated financial ratios and metrics derived from Phreesia's official financial filings.

Metric	2025	2024	2023	2022	2021	2020	2019	2018
Period end date	1/31/2025	1/31/2024	1/31/2023	1/31/2022	1/31/2021	1/31/2020	1/31/2019	1/31/2018
Growth Metrics	-	-	-	-	-	-	-	-
Revenue Growth	17.83%	26.84%	31.74%	43.42%	19.15%	24.92%	25.12%	0.00%
EBITDA Growth	75.18%	29.34%	-60.50%	-1,166.93%	-123.89%	-232.71%	194.53%	0.00%
EBIT Growth	58.85%	22.80%	-51.18%	-355.38%	-30.78%	-69.81%	20.55%	0.00%
NOPAT Growth	57.43%	22.70%	-51.14%	-355.05%	-67.81%	-61.13%	34.76%	0.00%
Net Income Growth	57.24%	22.29%	-49.07%	-332.95%	-34.49%	-34.73%	17.21%	0.00%
EPS Growth	59.36%	25.30%	-41.77%	-243.48%	84.67%	81.66%	1.13%	0.00%
Operating Cash Flow Growth	200.01%	64.07%	-20.63%	-2,685.12%	249.88%	138.78%	80.88%	0.00%
Free Cash Flow Firm Growth	59.14%	-20.63%	11.72%	-271.26%	-93.40%	39.63%	0.00%	0.00%
Invested Capital Growth	12.20%	47.34%	1.99%	108.94%	57.73%	34.86%	0.00%	0.00%
Revenue Q/Q Growth	3.62%	5.45%	7.08%	8.23%	6.44%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	46.28%	9.77%	4.92%	-63.51%	-78.48%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	30.03%	7.01%	3.69%	-49.12%	-13.72%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	27.44%	6.98%	3.71%	-48.85%	-16.36%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	29.30%	5.11%	4.57%	-48.06%	-19.37%	0.00%	0.00%	0.00%
EPS Q/Q Growth	30.14%	6.34%	6.15%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	148.19%	28.37%	19.68%	-128.79%	3,221.84%	119.45%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	15.24%	3.58%	30.48%	-84.09%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	2.48%	0.32%	-0.81%	73.54%	24.91%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-
Gross Margin	67.86%	65.19%	61.10%	61.83%	64.77%	64.16%	62.96%	62.71%
EBITDA Margin	-6.24%	-29.63%	-53.19%	-43.66%	-4.94%	-2.63%	2.48%	-3.28%
Operating Margin	-13.84%	-38.30%	-62.85%	-54.78%	-17.27%	-12.26%	-9.50%	-18.23%
EBIT Margin	-13.37%	-38.29%	-62.91%	-54.82%	-17.27%	-15.73%	-11.57%	-18.22%
Profit (Net Income) Margin	-13.94%	-38.42%	-62.71%	-55.41%	-18.36%	-16.26%	-15.08%	-22.79%
Tax Burden Percent	104.87%	101.14%	100.28%	100.15%	100.18%	91.94%	100.00%	100.00%
Interest Burden Percent	99.41%	99.20%	99.40%	100.93%	106.13%	112.46%	130.31%	125.04%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-21.85%	-64.90%	-104.85%	-94.77%	-39.38%	-34.73%	-50.62%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	2.93%	-31.12%	-82.45%	-80.44%	-32.57%	18.96%	-105.37%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-0.82%	14.13%	54.88%	60.05%	24.43%	-6.95%	722.43%	0.00%
Return on Equity (ROE)	-22.67%	-50.77%	-49.96%	-34.72%	-14.95%	-41.68%	671.81%	0.00%
Cash Return on Invested Capital (CROIC)	-33.35%	-103.18%	-106.82%	-165.29%	-84.18%	-64.42%	-250.62%	0.00%
Operating Return on Assets (OROA)	-14.80%	-36.86%	-40.88%	-28.47%	-10.58%	-18.01%	-19.50%	0.00%
Return on Assets (ROA)	-15.43%	-36.98%	-40.75%	-28.78%	-11.24%	-18.62%	-25.42%	0.00%
Return on Common Equity (ROCE)	-22.67%	-50.77%	-49.96%	-34.72%	-14.95%	46.70%	31,608.97%	0.00%
Return on Equity Simple (ROE_SIMPLE)	-22.10%	-54.44%	-61.20%	-28.32%	-10.37%	-19.92%	7.14%	0.00%
Net Operating Profit after Tax (NOPAT)	-41	-96	-124	-82	-18	-11	-6.65	-10
NOPAT Margin	-9.69%	-26.81%	-44.00%	-38.35%	-12.09%	-8.58%	-6.65%	-12.76%
Net Nonoperating Expense Percent (NNEP)	-24.79%	-33.78%	-22.40%	-14.33%	-6.81%	-53.68%	54.75%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	-14.47%	-36.34%	-41.79%	-	-	-	-	-
Cost of Revenue to Revenue	32.14%	34.81%	38.90%	38.17%	35.23%	35.84%	37.04%	37.29%
SG&A Expenses to Revenue	18.25%	22.43%	28.62%	32.21%	27.21%	24.41%	20.10%	23.60%
R&D to Revenue	27.96%	31.53%	32.48%	24.51%	15.22%	14.92%	14.36%	14.25%
Operating Expenses to Revenue	81.70%	103.50%	123.95%	116.62%	82.03%	76.42%	72.47%	80.94%
Earnings before Interest and Taxes (EBIT)	-56	-136	-177	-117	-26	-20	-12	-15
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-26	-106	-149	-93	-7.35	-3.28	2.47	-2.62
Valuation Ratios	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	6.25	5.64	6.87	3.83	10.95	10.92	0.00	0.00
Price to Tangible Book Value (P/TBV)	15.31	14.49	9.53	4.52	11.92	12.13	0.00	0.00
Price to Revenue (P/Rev)	3.94	3.98	7.04	7.50	19.39	8.91	1.67	2.09
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	8.06	7.65	15.20	11.12	47.90	29.54	15.40	0.00
Enterprise Value to Revenue (EV/Rev)	3.78	3.77	6.44	6.09	18.00	8.38	4.05	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	163.53	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	48.99	0.00	0.00	0.00	925.93	1,266.33	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-
Debt to Equity	0.06	0.05	0.03	0.03	0.04	0.23	-7.20	0.00
Long-Term Debt to Equity	0.03	0.02	0.01	0.02	0.02	0.21	-6.76	0.00
Financial Leverage	-0.28	-0.45	-0.67	-0.75	-0.75	-0.37	-6.86	0.00
Leverage Ratio	1.47	1.37	1.23	1.21	1.33	2.24	-13.22	0.00
Compound Leverage Factor	1.46	1.36	1.22	1.22	1.41	2.52	-17.22	0.00
Debt to Total Capital	5.76%	4.36%	2.67%	3.08%	4.13%	18.98%	116.13%	0.00%
Short-Term Debt to Total Capital	2.86%	2.30%	1.75%	1.35%	1.77%	1.85%	7.07%	0.00%
Long-Term Debt to Total Capital	2.90%	2.05%	0.92%	1.72%	2.36%	17.13%	109.06%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	742.74%	0.00%
Common Equity to Total Capital	94.24%	95.64%	97.33%	96.92%	95.87%	81.02%	-758.87%	0.00%
Debt to EBITDA	-0.62	-0.11	-0.05	-0.14	-1.54	-7.27	13.06	0.00
Net Debt to EBITDA	2.60	0.72	1.13	3.23	28.23	20.25	12.43	0.00
Long-Term Debt to EBITDA	-0.31	-0.05	-0.02	-0.08	-0.88	-6.56	12.26	0.00
Debt to NOPAT	-0.40	-0.12	-0.06	-0.16	-0.63	-2.23	-4.86	0.00
Net Debt to NOPAT	1.67	0.80	1.37	3.68	11.54	6.21	-4.63	0.00
Long-Term Debt to NOPAT	-0.20	-0.06	-0.02	-0.09	-0.36	-2.01	-4.56	0.00
Altman Z-Score	6.02	4.37	11.91	11.63	26.96	10.33	-2.26	0.00
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	212.04%	-4,605.04%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-
Current Ratio	1.78	1.78	3.32	5.65	4.95	3.72	1.19	0.00
Quick Ratio	1.38	1.38	2.89	5.17	4.51	3.18	0.63	0.00
Cash Flow Metrics	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-62	-152	-126	-143	-38	-20	-33	0.00
Operating Cash Flow to CapEx	134.42%	-129.01%	-343.94%	-242.53%	15.56%	6.70%	-21.66%	-93.12%
Free Cash Flow to Firm to Interest Expense	0.00	-135.86	0.00	-131.57	-24.42	-8.12	-9.39	0.00
Operating Cash Flow to Interest Expense	0.00	-28.96	0.00	-68.92	1.84	0.34	-0.61	-3.06
Operating Cash Flow Less CapEx to Interest Expense	0.00	-51.41	0.00	-97.34	-9.97	-4.70	-3.41	-6.34
Efficiency Ratios	-	-	-	-	-	-	-	-
Asset Turnover	1.11	0.96	0.65	0.52	0.61	1.14	1.69	0.00
Accounts Receivable Turnover	6.06	6.13	6.13	6.15	5.83	6.56	6.21	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	20.70	18.47	0.00	0.00	0.00	8.70	7.03	0.00
Accounts Payable Turnover	19.14	12.84	13.70	17.12	10.07	9.16	9.87	0.00
Days Sales Outstanding (DSO)	60.20	59.55	59.55	59.32	62.64	55.65	58.73	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	19.07	28.43	26.65	21.32	36.25	39.86	37.00	0.00
Cash Conversion Cycle (CCC)	41.13	31.12	32.90	38.00	26.39	15.79	21.74	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-
Invested Capital	197	175	119	117	56	35	26	0.00
Invested Capital Turnover	2.26	2.42	2.38	2.47	3.26	4.05	7.61	0.00
Increase / (Decrease) in Invested Capital	21	56	2.32	61	20	9.16	26	0.00
Enterprise Value (EV)	1,586	1,342	1,809	1,298	2,676	1,046	404	0.00
Market Capitalization	1,654	1,418	1,977	1,598	2,883	1,112	167	167
Book Value per Share	$4.56	$4.52	$5.46	$8.14	$5.96	$2.84	($114.35)	$0.00
Tangible Book Value per Share	$1.86	$1.76	$3.93	$6.89	$5.48	$2.55	($119.50)	$0.00
Total Capital	281	263	296	431	275	126	28	0.00
Total Debt	16	11	7.90	13	11	24	32	0.00
Total Long-Term Debt	8.15	5.40	2.73	7.42	6.47	22	30	0.00
Net Debt	-68	-76	-169	-301	-207	-66	31	0.00
Capital Expenditures (CapEx)	24	25	26	31	19	12	9.83	12
Debt-free, Cash-free Net Working Capital (DFCFNWC)	13	4.10	12	9.93	3.36	8.19	5.81	0.00
Debt-free Net Working Capital (DFNWC)	97	92	189	324	222	99	7.35	0.00
Net Working Capital (NWC)	89	86	183	318	217	96	5.39	0.00
Net Nonoperating Expense (NNE)	18	41	53	36	9.32	9.58	8.42	8.00
Net Nonoperating Obligations (NNO)	-68	-76	-169	-301	-207	-66	31	0.00
Total Depreciation and Amortization (D&A)	30	31	27	24	18	16	14	12
Debt-free, Cash-free Net Working Capital to Revenue	3.12%	1.15%	4.23%	4.66%	2.26%	6.57%	5.82%	0.00%
Debt-free Net Working Capital to Revenue	23.18%	25.71%	67.13%	151.82%	149.41%	78.94%	7.36%	0.00%
Net Working Capital to Revenue	21.26%	24.01%	65.29%	149.09%	146.14%	77.08%	5.39%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.02)	($2.51)	($3.36)	($2.37)	($0.69)	($4.50)	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	57.59M	54.56M	52.44M	49.89M	44.90M	37.52M	0.00	0.00
Adjusted Diluted Earnings per Share	($1.02)	($2.51)	($3.36)	($2.37)	($0.69)	($4.50)	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	57.59M	54.56M	52.44M	49.89M	44.90M	37.52M	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	($0.69)	($4.50)	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	58.77M	56.39M	53.36M	51.95M	39.52M	20.30M	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	-41	-96	-124	-82	-18	-11	-6.65	-10
Normalized NOPAT Margin	-9.69%	-26.81%	-44.00%	-38.35%	-12.09%	-8.58%	-6.65%	-12.76%
Pre Tax Income Margin	-13.29%	-37.99%	-62.53%	-55.33%	-18.32%	-17.69%	-15.08%	-22.79%
Debt Service Ratios	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	-122.03	0.00	-107.84	-16.32	-8.03	-3.30	-3.99
NOPAT to Interest Expense	0.00	-85.45	0.00	-75.44	-11.42	-4.38	-1.90	-2.80
EBIT Less CapEx to Interest Expense	0.00	-144.48	0.00	-136.25	-28.13	-13.07	-6.11	-7.28
NOPAT Less CapEx to Interest Expense	0.00	-107.90	0.00	-103.85	-23.23	-9.42	-4.70	-6.08
Payout Ratios	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	-73.70%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	-1.06%	-104.33%	-1.29%	0.00%

This table displays calculated financial ratios and metrics derived from Phreesia's official financial filings.

Metric	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Period end date	1/31/2025	10/31/2024	7/31/2024	4/30/2024	1/31/2024	10/31/2023	7/31/2023	4/30/2023	1/31/2023	10/31/2022	7/31/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	15.45%	16.57%	18.97%	20.72%	24.05%	25.33%	26.47%	32.34%	32.00%	30.74%	33.05%
EBITDA Growth	107.62%	77.31%	67.20%	58.97%	35.27%	25.98%	25.55%	30.93%	19.28%	-9.51%	-122.47%
EBIT Growth	81.71%	56.42%	53.10%	48.74%	25.86%	19.81%	20.29%	25.05%	14.55%	-11.62%	-93.73%
NOPAT Growth	74.26%	56.80%	53.40%	48.76%	25.71%	19.51%	20.24%	25.09%	14.59%	-11.39%	-94.62%
Net Income Growth	79.15%	54.91%	51.01%	47.45%	19.40%	20.48%	21.30%	26.76%	18.15%	-10.52%	-91.51%
EPS Growth	80.00%	56.90%	54.41%	50.00%	23.61%	23.68%	23.60%	29.29%	23.40%	-7.04%	-85.42%
Operating Cash Flow Growth	628.14%	191.68%	218.54%	94.72%	80.64%	69.59%	52.98%	59.39%	58.14%	15.41%	-194.89%
Free Cash Flow Firm Growth	65.32%	65.22%	-46.55%	-153.12%	-155.24%	4.17%	55.33%	69.26%	67.71%	-69.53%	-194.64%
Invested Capital Growth	12.20%	9.83%	36.79%	48.73%	47.34%	45.69%	13.62%	2.73%	1.99%	78.43%	108.42%
Revenue Q/Q Growth	2.70%	4.59%	0.89%	6.54%	3.70%	6.74%	2.37%	9.48%	4.76%	7.72%	7.12%
EBITDA Q/Q Growth	128.99%	43.50%	22.06%	40.28%	13.73%	18.31%	2.52%	5.78%	1.35%	17.83%	9.56%
EBIT Q/Q Growth	61.43%	19.19%	11.02%	34.05%	8.09%	13.04%	2.74%	4.63%	0.59%	13.55%	8.55%
NOPAT Q/Q Growth	45.01%	19.62%	11.32%	34.34%	7.70%	13.29%	2.50%	4.80%	-0.01%	14.08%	8.42%
Net Income Q/Q Growth	55.63%	20.04%	8.67%	35.65%	4.05%	13.13%	2.04%	1.29%	5.34%	14.02%	8.83%
EPS Q/Q Growth	56.00%	19.35%	11.43%	36.36%	5.17%	14.71%	2.86%	2.78%	5.26%	14.61%	10.10%
Operating Cash Flow Q/Q Growth	181.00%	-47.70%	1,634.12%	76.58%	51.22%	32.38%	31.69%	14.09%	23.37%	-4.56%	41.00%
Free Cash Flow Firm Q/Q Growth	0.54%	56.34%	18.74%	1.72%	0.26%	-83.97%	-40.36%	0.90%	62.55%	14.25%	3.39%
Invested Capital Q/Q Growth	2.48%	4.36%	-2.98%	8.13%	0.32%	29.98%	5.49%	7.13%	-0.81%	1.37%	-4.63%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	69.40%	67.66%	67.87%	66.39%	66.56%	66.23%	64.70%	63.03%	63.49%	62.61%	59.59%
EBITDA Margin	1.46%	-5.16%	-9.56%	-12.37%	-22.08%	-26.53%	-34.67%	-36.41%	-42.31%	-44.93%	-58.90%
Operating Margin	-6.94%	-12.96%	-16.87%	-19.19%	-31.13%	-34.98%	-43.06%	-45.20%	-51.98%	-54.46%	-68.27%
EBIT Margin	-4.92%	-13.10%	-16.95%	-19.22%	-31.05%	-35.03%	-43.00%	-45.25%	-51.95%	-54.75%	-68.22%
Profit (Net Income) Margin	-5.83%	-13.49%	-17.64%	-19.48%	-32.26%	-34.86%	-42.84%	-44.76%	-49.64%	-54.95%	-68.83%
Tax Burden Percent	118.86%	103.17%	104.34%	102.65%	100.71%	101.18%	101.79%	100.82%	99.55%	100.52%	100.46%
Interest Burden Percent	99.65%	99.81%	99.73%	98.77%	103.17%	98.37%	97.87%	98.11%	96.00%	99.85%	100.45%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-10.96%	-20.04%	-28.91%	-31.65%	-52.75%	-56.12%	-76.12%	-75.80%	-86.72%	-106.81%	-133.76%
ROIC Less NNEP Spread (ROIC-NNEP)	-9.49%	-13.85%	-22.28%	-25.49%	-44.63%	-49.56%	-69.76%	-70.20%	-82.40%	-102.65%	-129.43%
Return on Net Nonoperating Assets (RNNOA)	2.65%	4.07%	8.04%	9.83%	20.26%	24.58%	40.13%	42.81%	54.85%	77.95%	102.28%
Return on Equity (ROE)	-8.31%	-15.98%	-20.87%	-21.81%	-32.48%	-31.54%	-35.99%	-32.99%	-31.87%	-28.86%	-31.48%
Cash Return on Invested Capital (CROIC)	-33.35%	-39.92%	-74.27%	-91.27%	-103.18%	-106.86%	-98.27%	-93.85%	-106.82%	-193.42%	-213.58%
Operating Return on Assets (OROA)	-5.44%	-14.14%	-18.81%	-19.78%	-29.88%	-30.66%	-35.83%	-33.56%	-33.76%	-31.01%	-34.23%
Return on Assets (ROA)	-6.45%	-14.56%	-19.58%	-20.06%	-31.05%	-30.52%	-35.70%	-33.19%	-32.26%	-31.12%	-34.54%
Return on Common Equity (ROCE)	-8.31%	-15.98%	-20.87%	-21.81%	-32.48%	-31.54%	-35.99%	-32.99%	-31.87%	-28.86%	-31.48%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-32.52%	-39.92%	-47.11%	0.00%	-54.52%	-61.73%	-61.62%	0.00%	-57.62%	-51.87%
Net Operating Profit after Tax (NOPAT)	-5.33	-9.69	-12	-14	-21	-22	-26	-27	-28	-28	-32
NOPAT Margin	-4.86%	-9.07%	-11.81%	-13.43%	-21.79%	-24.48%	-30.14%	-31.64%	-36.39%	-38.12%	-47.79%
Net Nonoperating Expense Percent (NNEP)	-1.47%	-6.19%	-6.62%	-6.15%	-8.12%	-6.56%	-6.36%	-5.60%	-4.33%	-4.16%	-4.33%
Return On Investment Capital (ROIC_SIMPLE)	-1.90%	-	-	-	-7.88%	-	-	-	-9.42%	-	-
Cost of Revenue to Revenue	30.60%	32.34%	32.13%	33.61%	33.44%	33.77%	35.30%	36.97%	36.51%	37.39%	40.41%
SG&A Expenses to Revenue	16.79%	18.38%	19.09%	18.82%	19.81%	22.09%	24.45%	23.71%	25.93%	26.81%	29.58%
R&D to Revenue	27.01%	27.45%	28.93%	28.53%	31.43%	31.16%	32.01%	31.57%	33.16%	31.01%	33.22%
Operating Expenses to Revenue	76.34%	80.62%	84.73%	85.58%	97.69%	101.21%	107.75%	108.23%	115.47%	117.07%	127.86%
Earnings before Interest and Taxes (EBIT)	-5.40	-14	-17	-19	-29	-32	-37	-38	-40	-40	-46
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1.60	-5.52	-9.76	-13	-21	-24	-30	-31	-32	-33	-40
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	6.25	4.15	5.70	4.63	5.64	2.85	6.89	6.40	6.87	4.48	3.52
Price to Tangible Book Value (P/TBV)	15.31	10.74	14.94	11.95	14.49	6.71	11.18	9.34	9.53	5.91	4.46
Price to Revenue (P/Rev)	3.94	2.61	3.67	3.13	3.98	2.23	5.33	5.60	7.04	5.47	5.01
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	8.06	5.18	7.42	5.83	7.65	3.80	11.82	12.17	15.20	10.29	8.42
Enterprise Value to Revenue (EV/Rev)	3.78	2.45	3.50	2.96	3.77	1.97	4.98	5.15	6.44	4.71	4.07
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	48.99	76.19	1,433.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.06	0.08	0.06	0.07	0.05	0.05	0.06	0.05	0.03	0.03	0.03
Long-Term Debt to Equity	0.03	0.04	0.03	0.03	0.02	0.03	0.03	0.03	0.01	0.01	0.01
Financial Leverage	-0.28	-0.29	-0.36	-0.39	-0.45	-0.50	-0.58	-0.61	-0.67	-0.76	-0.79
Leverage Ratio	1.47	1.45	1.41	1.41	1.37	1.32	1.29	1.26	1.23	1.19	1.17
Compound Leverage Factor	1.46	1.44	1.41	1.39	1.42	1.30	1.26	1.24	1.18	1.19	1.18
Debt to Total Capital	5.76%	7.00%	5.44%	6.11%	4.36%	4.89%	5.78%	4.93%	2.67%	2.81%	2.97%
Short-Term Debt to Total Capital	2.86%	3.24%	2.69%	2.88%	2.30%	2.43%	2.71%	2.52%	1.75%	1.66%	1.59%
Long-Term Debt to Total Capital	2.90%	3.76%	2.75%	3.23%	2.05%	2.46%	3.07%	2.41%	0.92%	1.14%	1.37%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	94.24%	93.00%	94.56%	93.89%	95.64%	95.11%	94.22%	95.07%	97.33%	97.19%	97.03%
Debt to EBITDA	-0.62	-0.39	-0.21	-0.19	-0.11	-0.12	-0.12	-0.10	-0.05	-0.06	-0.07
Net Debt to EBITDA	2.60	1.28	1.00	0.72	0.72	0.77	0.90	1.00	1.13	1.27	1.49
Long-Term Debt to EBITDA	-0.31	-0.21	-0.11	-0.10	-0.05	-0.06	-0.06	-0.05	-0.02	-0.02	-0.03
Debt to NOPAT	-0.40	-0.34	-0.21	-0.20	-0.12	-0.13	-0.14	-0.12	-0.06	-0.07	-0.08
Net Debt to NOPAT	1.67	1.12	0.98	0.76	0.80	0.87	1.04	1.19	1.37	1.56	1.83
Long-Term Debt to NOPAT	-0.20	-0.18	-0.11	-0.11	-0.06	-0.07	-0.07	-0.06	-0.02	-0.03	-0.04
Altman Z-Score	6.45	3.48	5.91	4.11	5.32	2.39	9.19	9.71	13.13	10.16	8.67
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.78	1.74	1.77	1.76	1.78	2.02	2.58	2.89	3.32	3.94	4.40
Quick Ratio	1.38	1.40	1.40	1.35	1.38	1.63	2.14	2.44	2.89	3.49	4.00
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-27	-27	-62	-76	-77	-77	-42	-30	-30	-81	-94
Operating Cash Flow to CapEx	230.32%	138.33%	149.41%	-13.24%	-39.14%	-118.81%	-159.70%	-224.69%	-240.93%	-308.38%	-339.08%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-456.40
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-96.33
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-124.73
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.11	1.08	1.11	1.03	0.96	0.88	0.83	0.74	0.65	0.57	0.50
Accounts Receivable Turnover	6.06	6.29	6.77	6.27	6.13	6.64	6.33	6.07	6.13	6.57	6.34
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	20.70	17.66	0.00	0.00	18.47	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	19.14	9.95	17.36	17.78	12.84	10.92	12.93	16.88	13.70	9.13	12.51
Days Sales Outstanding (DSO)	60.20	58.04	53.91	58.21	59.55	54.98	57.64	60.12	59.55	55.52	57.55
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	19.07	36.70	21.02	20.52	28.43	33.42	28.23	21.62	26.65	39.98	29.17
Cash Conversion Cycle (CCC)	41.13	21.34	32.88	37.69	31.12	21.56	29.41	38.49	32.90	15.54	28.38
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	197	192	184	190	175	175	135	128	119	120	118
Invested Capital Turnover	2.26	2.21	2.45	2.36	2.42	2.29	2.53	2.40	2.38	2.80	2.80
Increase / (Decrease) in Invested Capital	21	17	49	62	56	55	16	3.39	2.32	53	62
Enterprise Value (EV)	1,586	994	1,365	1,106	1,342	664	1,590	1,552	1,809	1,235	997
Market Capitalization	1,654	1,057	1,432	1,169	1,418	754	1,702	1,688	1,977	1,435	1,227
Book Value per Share	$4.56	$4.41	$4.38	$4.48	$4.52	$4.79	$4.60	$4.94	$5.46	$6.10	$6.67
Tangible Book Value per Share	$1.86	$1.70	$1.67	$1.74	$1.76	$2.04	$2.84	$3.39	$3.93	$4.63	$5.26
Total Capital	281	274	266	269	263	278	262	277	296	330	359
Total Debt	16	19	14	16	11	14	15	14	7.90	9.25	11
Total Long-Term Debt	8.15	10	7.30	8.69	5.40	6.85	8.06	6.69	2.73	3.77	4.93
Net Debt	-68	-63	-67	-63	-76	-90	-113	-136	-169	-200	-230
Capital Expenditures (CapEx)	7.06	4.18	7.40	5.45	7.86	5.31	5.84	6.08	6.60	6.73	5.85
Debt-free, Cash-free Net Working Capital (DFCFNWC)	13	7.50	4.29	11	4.10	4.20	14	14	12	10	9.54
Debt-free Net Working Capital (DFNWC)	97	89	86	90	92	108	141	164	189	220	250
Net Working Capital (NWC)	89	80	79	83	86	101	134	157	183	214	245
Net Nonoperating Expense (NNE)	1.06	4.71	5.96	6.13	9.94	9.51	11	11	10	12	14
Net Nonoperating Obligations (NNO)	-68	-63	-67	-63	-76	-90	-113	-136	-169	-200	-230
Total Depreciation and Amortization (D&A)	6.99	8.47	7.55	6.93	8.52	7.78	7.15	7.42	7.38	7.18	6.32
Debt-free, Cash-free Net Working Capital to Revenue	3.12%	1.85%	1.10%	2.90%	1.15%	1.24%	4.32%	4.77%	4.23%	3.83%	3.89%
Debt-free Net Working Capital to Revenue	23.18%	22.03%	22.08%	24.18%	25.71%	31.84%	44.30%	54.46%	67.13%	83.72%	102.08%
Net Working Capital to Revenue	21.26%	19.84%	20.24%	22.11%	24.01%	29.84%	42.07%	52.15%	65.29%	81.63%	99.75%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.11)	($0.25)	($0.31)	($0.35)	($0.55)	($0.58)	($0.68)	($0.70)	($0.72)	($0.76)	($0.89)
Adjusted Weighted Average Basic Shares Outstanding	57.59M	57.89M	57.50M	56.67M	54.56M	55.25M	53.79M	53.35M	52.44M	52.61M	52.33M
Adjusted Diluted Earnings per Share	($0.11)	($0.25)	($0.31)	($0.35)	($0.55)	($0.58)	($0.68)	($0.70)	($0.72)	($0.76)	($0.89)
Adjusted Weighted Average Diluted Shares Outstanding	57.59M	57.89M	57.50M	56.67M	54.56M	55.25M	53.79M	53.35M	52.44M	52.61M	52.33M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	58.77M	58.12M	57.77M	57.40M	56.39M	55.63M	55.21M	53.66M	53.36M	52.75M	52.53M
Normalized Net Operating Profit after Tax (NOPAT)	-5.33	-9.69	-12	-14	-21	-22	-26	-27	-28	-28	-32
Normalized NOPAT Margin	-4.86%	-9.07%	-11.81%	-13.43%	-21.79%	-24.48%	-30.14%	-31.64%	-36.39%	-38.12%	-47.79%
Pre Tax Income Margin	-4.90%	-13.07%	-16.90%	-18.98%	-32.03%	-34.46%	-42.08%	-44.40%	-49.87%	-54.66%	-68.52%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-224.74
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-157.45
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-253.15
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-185.86
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Phreesia's Financials

When does Phreesia's financial year end?

According to the most recent income statement we have on file, Phreesia's fiscal year ends in January. Their fiscal year 2025 ended on January 31, 2025.

How has Phreesia's net income changed over the last 7 years?

Phreesia's net income appears to be on an upward trend, with a most recent value of -$58.53 million in 2025, rising from -$18.19 million in 2018. The previous period was -$136.89 million in 2024. See where experts think Phreesia is headed by visiting Phreesia's forecast page.

What is Phreesia's operating income?

Phreesia's total operating income in 2025 was -$58.10 million, based on the following breakdown:

Total Gross Profit: $284.88 million
Total Operating Expenses: $342.98 million

How has Phreesia revenue changed over the last 7 years?

Over the last 7 years, Phreesia's total revenue changed from $79.83 million in 2018 to $419.81 million in 2025, a change of 425.9%.

How much debt does Phreesia have?

Phreesia's total liabilities were at $123.61 million at the end of 2025, a 4.0% increase from 2024, and a 93.9% increase since 2019.

How much cash does Phreesia have?

In the past 6 years, Phreesia's cash and equivalents has ranged from $1.54 million in 2019 to $313.81 million in 2022, and is currently $84.22 million as of their latest financial filing in 2025.

How has Phreesia's book value per share changed over the last 7 years?

Over the last 7 years, Phreesia's book value per share changed from 0.00 in 2018 to 4.56 in 2025, a change of 455.6%.

Related Companies

This page (NYSE:PHR) was last updated on 5/28/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Phreesia (PHR) Financials

Frequently Asked Questions About Phreesia's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Phreesia (PHR) Financials

Annual Income Statements for Phreesia

Quarterly Income Statements for Phreesia

Annual Cash Flow Statements for Phreesia

Quarterly Cash Flow Statements for Phreesia

Annual Balance Sheets for Phreesia

Quarterly Balance Sheets for Phreesia

Annual Metrics And Ratios for Phreesia

Quarterly Metrics And Ratios for Phreesia

Frequently Asked Questions About Phreesia's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools